Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-550,000
Closed -$28.3M 18
2018
Q4
$28.3M Sell
550,000
-450,000
-45% -$28.8M 2.79% 13
2018
Q3
$71.6M Hold
1,000,000
6.71% 7
2018
Q2
$69.4M Buy
1,000,000
+100,000
+11% +$6.68M 6.91% 6
2018
Q1
$59.3M Hold
900,000
6.03% 7
2017
Q4
$65M Hold
900,000
7.68% 5
2017
Q3
$53.5M Hold
900,000
7.15% 5
2017
Q2
$58.3M Hold
900,000
7.09% 4
2017
Q1
$61.2M Hold
900,000
7.4% 5
2016
Q4
$57.8M Sell
900,000
-200,000
-18% -$12.5M 7.36% 6
2016
Q3
$72.7M Buy
1,100,000
+100,000
+10% +$7.04M 9.49% 5
2016
Q2
$77.3M Sell
1,000,000
-100,000
-9% -$7.56M 9.8% 6
2016
Q1
$80.7M Buy
1,100,000
+350,000
+47% +$23.6M 9.87% 4
2015
Q4
$52.3M Hold
750,000
6.84% 7
2015
Q3
$54.2M Buy
+750,000
New +$58.2M 5.73% 10

Other funds holding DVA

Consulta's DVA Position: Q1 2019 in Review

Consulta sold out of DaVita (DVA) in Q1 2019, closing a stake of 550,000 shares — an estimated $28.3M sold.

Consulta first reported a position in DVA in Q3 2015 and held it in 14 quarters. The position peaked at $80.7M in Q1 2016. 440 funds tracked by Wall St. Rank hold DVA as of Q1 2019.

  • Consulta reported no remaining DaVita position as of Q1 2019 after selling out during the quarter.
  • Consulta sold 550,000 DaVita shares in Q1 2019, an estimated $28.3M.
  • Consulta first reported a position in DaVita in Q3 2015 and held it in 14 quarters.
  • Consulta's DaVita position peaked at $80.7M in Q1 2016.
  • 440 funds tracked by Wall St. Rank held DaVita as of Q1 2019.

Based on Consulta's 13F filing for Q1 2019, filed 15 May 2019.